How fast should I expect weight to fall after starting IV diuresis?

Many teams aim for steady net-negative balances rather than abrupt crashes—faster drops risk hypotension, renal injury and electrolyte chaos. Trends matter more than single points.

When is it reasonable to hold ACEi/ARB/ARNI in acute decompensation?

Guidelines prioritise perfusion; if creatinine surges with symptomatic hypotension or hyperkalaemia after aggressive diuresis, specialists often pause or reduce RAAS drugs temporarily—never improvise long holds without prescriber documentation.

Why do natriuretic peptides sometimes look normal in obese patients?

Adipose tissue may lower circulating BNP/NT-proBNP for a given filling pressure—interpret alongside echo and exam.

Can I still uptitrate beta-blockers during outpatient congestion?

Usually teams stabilise congestion first—starting or aggressively uptitrating beta-blockers when the patient is wet and tachypnoeic can worsen symptoms. Once euvolemia returns, structured titration resumes.

What potassium threshold should prompt holding spironolactone?

Institution-specific, but serum K 5.5 mmol/L typically triggers hold/review with repeat labs within 24 h; 6.0 mmol/L is an emergency pathway in most protocols.

How do I reconcile COPD versus HF when the patient wheezes?

Correlate with imaging, natriuretic peptides, recent steroids or antibiotics, and prior PFTs—often both diseases coexist; treatment is not either/or.

What discharge education actually reduces readmissions?

Daily weights same scale/time, sodium literacy, warning symptoms, medication synchronization, and early clinic or phone follow-up.

Who needs anticoagulation for HF with atrial fibrillation?

Stroke-prophylaxis decisions use CHA2DS2-VASc and bleeding risk tools—ensure renal dosing, interaction checks, and patient understanding of bleeding red flags.

Heart Failure: HFrEF vs HFpEF, GDMT, Diuresis & Red Flags | NurseOnShift

🫀 Cardiovascular · Pump failure & congestion

Heart Failure: HFrEF vs HFpEF, GDMT, Diuresis & Red Flags

Ward-facing reference on LVEF phenotypes, natriuretic peptide clues, echocardiographic anchors, four-pillar GDMT for HFrEF, congestion monitoring, cardiorenal trade-offs, and escalation when perfusion fails.

⏱️26 min read

📅Updated May 3, 2026

✓Medically Reviewed

✍️

Written by

Sid Ahmed Abdala Balal

RGN

🩺

Reviewed by

Adam Sayedi

✨

Featured snippet

Heart failure is a clinical syndrome of impaired ventricular filling or ejection that produces typical symptoms (shortness of breath, orthopnoea, reduced exercise tolerance) and signs (raised JVP, pulmonary crackles, dependent edema) at rest or on exertion—most often due to structural cardiac disease. Contemporary care stratifies by LVEF into HFrEF, HFmrEF and HFpEF, pairs symptoms with NT-proBNP/BNP where appropriate, confirms with echocardiography, then sequences guideline-directed medical therapy (GDMT), diuresis for congestion, and device or advanced therapies when criteria align.

Clinical snapshot: Treat congestion first when perfusion is threatened—then uptitrate neurohormonal blockade only when blood pressure, renal function and potassium permit.

🔑Key Takeaways

Use LVEF categories (HFrEF typically ≤40%, HFmrEF 41–49%, HFpEF ≥50% in current ACC/AHA/HFSA language) to choose evidence-based drug classes—especially the four GDMT pillars for HFrEF: renin–angiotensin modulation, proven beta-blockade, mineralocorticoid receptor antagonism when safe, and SGLT2 inhibition.
Elevated NT-proBNP/BNP supports diagnosis and risk stratification but rises with age, renal dysfunction and rapid atrial fibrillation—pair biomarkers with examination and imaging rather than treating a single number as definitive.
Loop diuretics such as furosemide remain first-line for symptomatic congestion—success is judged by weight trajectory, symptom relief, creatinine and electrolytes, not the first bolus alone.
Common precipitants include dietary sodium excess, missed neurohormonal blockers, infection or ischaemia, uncontrolled arrhythmia with rapid ventricular response, and NSAID or steroid exposure—medication reconciliation on admission is preventive medicine.
Escalate early for hypotension with cool peripheries, rising lactate, sudden hypoxia, or ECG ischaemia—acute coronary syndromes and pulmonary embolism belong on every acute dyspnoea differential.

⚡ Quick Facts

📊

HFrEF LVEF

≤40% typical cutoff

🧪

BNP context

Higher if AF / older age

💧

Weight signal

Same scale AM comparisons

⚠️

MRA monitoring

Recheck K+ after titration

💡 Clinical Pearl

Diuretic “resistance” is often adherence, NSAID co-ingestion, gut oedema, or hypoperfusion—not destiny. Before escalating inotropes, reconcile PO versus IV loops, pause nephrotoxins when safe, and read the creatinine–eGFR relationship with nephrology thresholds—pharmacist-led choreography beats nursing guesswork.

📋 Contents

❓

What is Heart Failure?

Heart failure is less a single lesion than a syndrome: the myocardium (or valves, rhythm, or pericardial constraint) fails to maintain cardiac output and/or filling pressures compatible with organ perfusion and tissue oxygen delivery. Left-sided failure elevates left-heart pressures and drives pulmonary congestion; right-sided failure raises systemic venous pressure and produces peripheral congestion, hepatic engorgement and renal venous hypertension. Neurohormonal activation (RAAS, sympathetic nervous system, natriuretic peptide release) initially compensates but promotes remodelling, fibrosis and arrhythmia vulnerability over months to years.

In everyday practice you operationalise the definition: typical symptoms such as fatigue and exertional dyspnoea plus objective evidence of cardiac structural or functional abnormality on transthoracic echo—or elevated natriuretic peptides when imaging is not yet available. HF with reduced EF (HFrEF) reflects systolic pump weakness; HF with preserved EF (HFpEF) reflects ventricular diastolic stiffness, chronotropic incompetence, atrial dysfunction and vascular–microvascular interplay despite near-normal EF. HFmrEF occupies the mid-range; labels change as therapy shifts EF or as recovery occurs after revascularisation or myocarditis.

📊

Phenotypes & functional class

Guidelines emphasise LVEF triage because randomised evidence clusters there. NYHA class still governs symptomatic intensity for bedside handover despite subjectivity—pair it with six-minute walk data or activity trackers where heart failure programmes capture them.

Category	Typical LVEF	Therapy emphasis
HFrEF	≤40%	GDMT pillars, device candidacy, careful diuresis; consider digoxin for rate control in selected atrial arrhythmias when prescribed.
HFmrEF	41–49%	Re-measure EF after optimisation; many teams extrapolate tolerated HFrEF therapies while trial evidence evolves.
HFpEF	≥50%	Pressure and volume management, comorbidity control (BP, rate control in AF, glycaemia, adiposity); SGLT2 inhibitors anchor newer outcome data in this space.

On a small screen, swipe or scroll sideways to see the full table.

Exact EF bands and labels shift between guideline cycles—map order sets to your hospital’s adopted ACC/AHA/HFSA or ESC synopsis rather than memorising one historic diagram.

🚨 Do not miss: shock, ischaemia, massive PE

Features that demand immediate senior and critical-care review:

Hypotension with cool, mottled peripheries, narrowing pulse pressure, or rising lactate despite diuresis—cardiogenic shock trajectory until proven otherwise.
Acute pulmonary oedema with typical ischaemic chest pain or dynamic ST changes—activate acute coronary syndrome pathways in parallel with heart failure care.
Sudden hypoxia with pleuritic pain, RV strain pattern, or bilateral DVT clues—expedite evaluation for pulmonary embolism even when natriuretic peptides are elevated.

Immediate actions: High-flow oxygen per protocol, continuous monitoring, ECG within minutes, early cardiology/intensivist notification, withhold blind fluid boluses in obvious warm–wet pulmonary oedema, and prepare vasoactive or mechanical circulatory support only under explicit prescription.

🔍

How it presents

Patients language fatigue as normal ageing until orthopnoea, pillow count or bending intolerance reveals fluid redistribution. Older adults may present with confusion, anorexia or syncope before classic lung findings.

Congestion-forward cues

Exertional and paroxysmal nocturnal dyspnoea, cough with frothy or blood-tinged sputum during flash pulmonary oedema.
Orthopnoea and bendopnoea (dyspnoea when leaning forward).
Hepatic fullness, early satiety, ascites when right-sided failure predominates.

Low-output and systemic cues

Fatigue, anorexia, cachectic appearance in advanced neurohormonal burnout.
Oliguria, worsening renal function, dizziness on standing after orthostatic checks.
Palpitations or irregular pulse when atrial fibrillation drives rapid ventricular rates.

🧬

Causes and risk factors

Ischaemic scar from prior heart attack, chronic pressure overload, valvular lesions, tachycardia-mediated dysfunction, alcoholic or chemotherapy toxins, and infiltrative storage diseases converge on maladaptive remodelling. Nurses active in admitting medicine should chart which drivers are modifiable today (ischaemia, infection, tachyarrhythmia, dietary sodium, NSAIDs) versus structural history.

High-yield comorbid interfaces

Chronic kidney disease and cardiorenal syndrome—fluid, RAAS blockade and MRA therapy tighten potassium and creatinine trajectories together.
COPD sharing dyspnoea and wheeze—correlate symptoms with natriuretic peptides, B-lines on focused lung ultrasound where credentialed, and hyperinflation on chest X-ray.
Diabetes type 2, obesity and metabolic syndrome amplifying HFpEF incidence.

🔬

How is it diagnosed?

Clinical assessment

Quantify JVP trend when feasible, listen for S3 where acoustic conditions allow, document apex position, and formalise orthopnoea in pillow equivalents. Capture admission weight on the unit scale that will be used for discharge teaching.

Laboratory investigations

NT-proBNP or BNP—apply age- and renal-adjusted interpretation locally.
Renal panel with eGFR trajectory; electrolyte panel before and after MRA or aggressive diuresis.
Troponin when ischaemia, demand injury or myocarditis is plausible.

Imaging

Echocardiogram remains the cornerstone for EF, diastolic indices, valve disease, right ventricular performance and haemodynamic clues for advanced therapies.

🧩

Differential diagnoses

Mimic	Bedside pivot
COPD / asthma flare	Wheeze dominant, prolonged expiration, prior spirometry, paCO₂ trajectory.
Ischaemia	Pressure-type symptoms, troponin kinetics, regional wall motion abnormality on echo.
PE with right heart strain	Risk scoring, D-dimer or CTPA pathway, disproportionate hypoxia.
Anaemia / deconditioning	Disproportionate fatigue with clear lungs, haemoglobin pattern.

On a small screen, swipe or scroll sideways to see the full table.

💊

Treatment options

Decongest with oral or IV furosemide (or bumetanide/torasemide per formulary) guided by symptom change, net balance goals and renal response. Mortality benefits come from neurohormonal antagonism once euvolemia is achievable.

Guideline-directed medical therapy (HFrEF)

RAAS inhibition—ACEi such as lisinopril, ARB, or sacubitril–valsartan sequence per cardiology when eligible.
Evidence-based beta-blockade with metoprolol succinate, bisoprolol or carvedilol per local pathway.
Spironolactone or eplerenone when EF remains reduced and renal function plus potassium permit—never silent initiation without lab follow-up.
SGLT2 inhibitors for HF with reduced EF regardless of diabetes where approved—align counselling with hypoglycaemia and genital infection teaching per protocol.

Devices and advanced options

ICD and CRT when QRS morphology, EF and symptomatic status satisfy criteria—nursing documents device checks, home transmission alerts and arrhythmia symptoms.
Mechanical circulatory support or transplant referral for refractory Stage D physiology—requires structured multidisciplinary candidacy assessment.

HFpEF snapshot

Sodium and symptom-guided diuresis still apply; comorbidity control and SGLT2 pathways increasingly define outpatient stabilisation alongside rehabilitation referrals.

📋

Clinical Practice Considerations

Operationalise rounds with simultaneous goals-of-care clarity: daily weights through intake and output monitoring, scheduled vital signs monitoring including orthostasis after diuretic pivots, and SpO₂ trending with pulse oximetry during mobilisation trials.

Monitoring intervals

Recheck electrolytes and eGFR ≈1–2 weeks after starting or doubling MRAs, ARNI, or aggressive diuresis bundles—sooner if baseline potassium >4.8 mmol/L or eGFR <45.
Daily weights during decompensation; once euvolemic for 48–72 h, pivot toward education and outpatient equipoise.
Heart failure clinic or phone follow-up within ~7–14 days of discharge when available—document pending labs in handoff.

Clinical decision flow (shift-ready)

Airway and breathing — upright positioning, oxygen therapy titrated to local COPD hypercapnia rules.
Circulation snapshot — BP trends, lactate if shock suspected, urine output hourly when diuresing aggressively.
Decongest — execute prescribed diuretic strategy; avoid unsupervised fluid challenges.
Protect kidneys — stagger nephrotoxins; communicate creatinine jumps early.
Teach explicit red flags — ≥2 kg overnight gain, worsening orthopnoea, syncope.

Bedside monitoring checklist

Neurovascular checks when adding nitrates or starting ionotropic drips.
Strict I/O, abdominal girth in ascites, glucometry if on SGLT2 with intercurrent illness.
Medication reconciliation excising NSAIDs and problematic negative inotropes unless irreplaceable.

⚠️

Possible complications

Refractory congestion needing ultrafiltration, vasodilator infusions or ICU escalation.
Worsening cardiorenal syndrome with rising creatinine—tension between congestion relief and perfusion pressure.
Ventricular arrhythmias and sudden death risk despite optimisation—integrate device therapy documentation.
Thromboembolism from atrial stasis or low-output states—observe anticoagulation initiation plans.

🛡️

Prevention

Secondary prevention after MI follows cardiology timelines; blood pressure, diabetes and lipid control attenuate incident HF; vaccination and early infection treatment blunt decompensation spikes. Reinforce sodium literacy and alcohol moderation where they drive admissions.

📈

Prognosis and outlook

One-year mortality and readmission after hospitalised HF remain substantial but modern GDMT, devices and multidisciplinary disease-management programmes improve both—particularly when patients sustain target doses without recurrent wet exacerbations. HFpEF carries heavy symptom burden and healthcare utilisation even when LVEF looks “normal.”

👩‍⚕️

In Clinical Practice…

Documentation that survives handover

Timestamp weight, oxygen device and flow rate, mental status, cumulative urine output after diuretic doses, and precisely which high-stakes medications were held—with prescriber notification and response recorded.

Equity and literacy

Low-literacy patients may confuse sodium restriction with fluid restriction; use teach-back, translated leaflets, and visually explicit meal examples from dietitian partners.

🚨

When to Seek Emergency Care

🚨Escalate immediately

SpO₂ below unit-specific target despite escalating oxygen or new need for high-flow support.
Systolic BP <90 mmHg with altered mentation, anuria or rising lactate.
Recurrent ventricular arrhythmia, syncope, or crushing ischaemic pain.
Massive peripheral oedema with anuria—impending renal shutdown.

📚

NCLEX practice questions

These NCLEX-style clinical judgment practice items focus on the nursing priorities for this condition — recognise cues, escalate red flags, take safe action and evaluate outcomes (NCSBN Clinical Judgment Measurement Model) — through Priority FIRST, SATA, deterioration trends, multi-patient triage, ordered response, matrix matching and cloze drops on the topic of congestion scoring, GDMT safety, potassium monitoring on MRAs, oxygen titration and cardiogenic shock recognition—mirroring the Clinical Judgment Measurement Model focus on risk detection and correct sequencing.

Next step Timed NCLEX Next Gen–style scenarios on NurseOnShift